Mindray Medical International Ltd (ADR)  

(Public, NYSE:MR)   Watch this stock  
Find more results for Ronald Kern�
29.29
+0.05 (0.17%)
Oct 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 29.16 - 29.53
52 week 28.43 - 42.11
Open 29.16
Vol / Avg. 0.00/515,662.00
Mkt cap 3.46B
P/E 17.28
Div/yield 0.50/1.71
EPS 1.69
Shares 89.21M
Beta 1.11
Inst. own 114%
Nov 4, 2014
Q3 2014 Mindray Medical International Ltd Earnings Call - 8:00AM EST - Add to calendar
Nov 3, 2014
Q3 2014 Mindray Medical International Ltd Earnings Release - 4:00PM EST - Add to calendar
Aug 12, 2014
Q2 2014 Mindray Medical International Ltd Earnings Call - Webcast
Aug 11, 2014
Q2 2014 Mindray Medical International Limited Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 18.29% 18.99%
Operating margin 19.27% 17.32%
EBITD margin - 21.81%
Return on average assets 10.80% 10.57%
Return on average equity 16.48% 15.77%
Employees 7,900 -
CDP Score - -

Address

Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan
SHENZHEN, GNG 518057
China
+86-755-26582888 (Phone)
+86-755-26582680 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Mindray Medical International Limited (Mindray International), is a developer, manufacturer and marketer of medical devices worldwide. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. The Company provides after-sales services to distributors and hospitals in China through 32 local offices based in provincial capital cities. It also provides after-sales services to hospitals in the United States, the United Kingdom, France and Germany. In addition, the Company provides after-sales service to its international customers through its distribution channel where it does not engage in direct sales activities. In July 2013, Mindray Medical International Ltd completed the acquisition of ZONARE Medical Systems, Inc.

Officers and directors

Hang Xu Chairman of the Board
Age: 50
Bio & Compensation  - Reuters
Xiting Li President, Co-Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Minghe Cheng Co-Chief Executive Officer, Chief Strategic Officer
Age: 51
Bio & Compensation  - Reuters
Alex Lung Chief Financial Officer
Age: 41
Bio & Compensation  - Reuters
Jie Liu Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
Jianxin Wang Chief Administrative Officer
Bio & Compensation  - Reuters
May Li Chief Investment Officer
Bio & Compensation  - Reuters
Fannie Lin Fan Group General Counsel, Secretary of Board of Directors
Age: 40
Bio & Compensation  - Reuters
Ronald H. Ede Director
Age: 54
Bio & Compensation  - Reuters
Qiyao Wu Director
Age: 76
Bio & Compensation  - Reuters